Rupture of totally implantable central venous access devices (Intraports) in patients with cancer: report of four cases

• Main Authors: Filippou Georgios K, Tsikkinis Christoforos, Filippou Dimitrios K, Nissiotis Athanasios, Rizos Spiros
• Format: Article
• Language: English
• Published: BMC 2004-10-01
• Series: World Journal of Surgical Oncology
• Online Access: http://www.wjso.com/content/2/1/36

<p>Abstract</p> <p>Background</p> <p>Totally implantable central venous access devices (intraports) are commonly used in cancer patients to administer chemotherapy or parenteral nutrition. Rupture of intraport is a rare complication.</p> <p>Patients and methods</p> <p>During 3 years period, a total of 245 intraports were placed in cancer patients for chemotherapy. Four of these cases (two colon cancer and one each of pancreas and breast cancer) had rupture of the intraport catheter, these forms the basis of present report.</p> <p>Results</p> <p>Mean time <it>insitu </it>for intraports was 164∀35 days. Median follow-up time was 290 days and total port time <it>in situ </it>was 40180 days. The incidence of port rupture was 1 per 10,000 port days.</p> <p>Three of the 4 cases were managed by successful removal of catheters. In two of these the catheter was removed under fluoroscopic control using femoral route, while in the third patient the catheter (partial rupture) was removed surgically. One of the catheters could not be removed and migrated to right ventricle on manipulations.</p> <p>Conclusion</p> <p>Port catheter rupture is a rare but dreaded complication associated with subcutaneous port catheter device placement for chemotherapy. In case of such an event the patient should be managed by an experienced vascular surgeon and interventional radiologist, as in most cases the ruptured catheter can be retrieved by non operative interventional measures.</p>